Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.
Long Chain Fatty Acid Oxidation Disorders (LC-FAOD) and other Non-FAOD conditions, where applicable: Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.
Study Type
EXPANDED_ACCESS
Liquid for oral (PO) or enteral tube administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.